Johnny , New stuff being posted all the time here. Read some of Tonyindos posts. He has been digging up some great stuff.
NEU has a much bigger market scope than previously imagined and it appears that the company have a much better handle on how this all works and likelyhood of success than generally given credit for.
This oral formulation for age related memory loss could be the next LIPITOR. They have often stated they are in constant contact with potential partners. What is the possibility of a good partnering deal on this Oral NNZ2566 project.
The Big Pharma are scouring the planet looking for the right projects to take on.
time to go, page-5
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |